CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF ...
New production capacity strengthens MPM Medical's position as a leading U.S. manufacturer and follows the company's recent launch of collagen at-home wound care kits MESQUITE, Texas, Dec. 16, 2025 ...
Boston, MA, based Investment company Mpm Asset Management Llc (Current Portfolio) buys Oncorus Inc, sells Rhythm Pharmaceuticals Inc, Harpoon Therapeutics Inc during the 3-months ended 2021Q1, ...
Jan 5 (Reuters) - Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology company backed by major sector investor MPM BioImpact revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results